Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Biofrontera Inc. (BFRI)

NASDAQ

$1,25

$--

(0,00%)

Pre-Market

Biofrontera Inc. (BFRI) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Biofrontera Inc. (BFRI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,25, with a market capitalisation of $20,20M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,55 to $1,66. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$20,20M
Open	$1,25
Day's High	$292,60
Day's Low	$0,54
Previous Close	$1,19
Volume	1,71K
Average Volume	550,35K
P/E Ratio	--
52-Week High	$1,66
52-Week Low	$0,55
Dividend Yield	--
Earnings Date	--

Biofrontera Inc. (BFRI) Pre-Market Stock Price

Biofrontera Inc. (BFRI) is trading at $1,25 in pre-market trading as of 2026-09-16 08:44:00, up 4,62% ($0,06) from the previous close of $1,19

Pre-market trading shows how investors are pricing BFRI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Biofrontera Inc. (BFRI) 7-Day Stock Price Change

Over the past seven days, Biofrontera Inc. (BFRI) moved from $1,61 to $1,25, representing a decline of 22,67% ($0,37).

The stock traded between $1,17 and $1,66 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1,28 million shares, up versus the previous seven-day period, indicating higher trading activity.

BFRI 52-Week Price Position

Position in Range: 62,5%

52W Low$0,55

52W High$1,66

BFRI is currently trading at $1,25, placing it 62,5% of the way from its 52-week low of $0,55 to its 52-week high of $1,66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Biofrontera Inc. (BFRI)?

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Biofrontera Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	94
Exchange	NASDAQ
Company Website	https://www.biofrontera-us.com

How to Buy Biofrontera Inc. (BFRI) Stock on MEXC

Eligible investors can buy real shares of Biofrontera Inc. (BFRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BFRI and Place Your Order

Open the RealStocks trading page and search for BFRI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Biofrontera Inc. (BFRI) stock price today?

Biofrontera Inc. (BFRI) is currently trading at $ 1,25, up 4,62% ($0,06) from the previous close of $ 1,19. Intraday prices update in real time during regular trading hours.

2.Is BFRI stock going up or down today?

As of 2026-09-16 08:44:00, BFRI is trading at $ 1,25, up 4,62% ($0,06) from its previous close of $ 1,19. The stock has traded between $ 0,54 and $ 292,60 during today’s regular session. Past price movements do not guarantee future results.

3.What is BFRI pre-market price?

As of 2026-09-16 08:44:00, BFRI is trading at $ 1,25 in pre-market trading, up 4,62% ($0,06) from the previous close of $ 1,19. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BFRI after-hours price?

As of 2026-09-16 08:44:00, BFRI is trading at $ 1,24 in after-hours trading, up 4,54% ($0,05) from the regular-session close of $ 1,19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BFRI stock trading now?

BFRI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BFRI sit relative to its 52-week high and low?

Over the past 52 weeks, BFRI has traded between a low of $ 0,55 and a high of $ 1,66. At $ 1,25, the stock is positioned 62,5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Biofrontera Inc. in?

Biofrontera Inc. (BFRI) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Biofrontera Inc.'s market capitalisation and where is it listed?

Biofrontera Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 20,20M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BFRI valued in terms of P/E ratio and EPS?

BFRI trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Biofrontera Inc. pay a dividend?

Biofrontera Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.